Interferon-induced thyroid dysfunction in chronic hepatitis C-Reference-Cited by-同舟云学术

Interferon-induced thyroid dysfunction in chronic hepatitis C

Published:2009-06 Issue:6 Volume:24 Page:1017-1023
ISSN:0815-9319
Container-title:Journal of Gastroenterology and Hepatology
language:en
Short-container-title:

Author:

Jamil Khaleel M,Leedman Peter J,Kontorinis Nickolas,Tarquinio Lorenzo,Nazareth Saroja,McInerney Marion,Connelly Crystal,Flexman James,Burke Valerie,Metcalf Cecily,Cheng Wendy

Publisher

Wiley

Subject

Gastroenterology,Hepatology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/j.1440-1746.2008.05690.x/fullpdf

Reference26 articles.

1. Modelling hepatitis C virus incidence, prevalence and long-term sequelae in Australia, 2001;Law;Int. J. Epidemiol.,2003

2. Effects of adding ribavirin to interferon to treat chronic hepatitis C infection: a systematic review and meta-analysis of randomized trials;Brok;Arch. Intern. Med.,2005

3. Adherence to combination therapy enhances sustained response in genotype-1-infected patients with chronic hepatitis C;McHutchison;Gastroenterology,2002

4. Interferon-related thyroid autoimmunity and long-term clinical outcome of chronic hepatitis C;Morisco;Dig. Liver Dis.,2001

5. Increased risk of autoimmune thyroid disease in hepatitis C vs hepatitis B before, during, and after discontinuing interferon therapy;Fernandez-Soto;Arch. Intern. Med.,1998

Cited by 30 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A systematic review and meta-analysis of endocrine-related adverse events associated with interferon;Frontiers in Endocrinology;2022-08-05

2. Graves’ disease: Epidemiology, genetic and environmental risk factors and viruses;Best Practice & Research Clinical Endocrinology & Metabolism;2020-01

3. Long-term outcomes and risk factors of thyroid dysfunction during pegylated interferon and ribavirin treatment in patients with chronic hepatitis C infection in Taiwan;BMC Endocrine Disorders;2019-04-05

4. A RANDOMIZED CONTROL TRIAL TO ASSESS THE COMMON AND PERSISTENT ASSOCIATION OF THYROID IRREGULARITY AMONG HCV PATIENTS;INDO AM J PHARM SCI;2018

5. A RANDOMISED CONTROL TRIAL TO COMPARE THYROID DISORDER (TD) AMONG CHC (CHRONIC HEPATITIS C) PATIENTS: IFN-alpha Vs PEG-IFN THERAPY;INDO AM J PHARM SCI;2018